{"version":"1.0","type":"link","title":"SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer.","author_name":"Zhou Q 외","author_url":"https://prs-insight.online/author/Zhou%20Q","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97023","thumbnail_width":1200,"thumbnail_height":630}